Guest: Robert P. Frantz, M.D.
Host: Kyle Klarich, M.D.
Overview:
Pulmonary arterial hypertension (PAH) is a critical illness manifested by vasoconstriction and obliteration of the pulmonary arterial vasculature leading to rise in pulmonary artery strain and resistance and culminating in proper coronary heart failure. Listeners will study extra about conventional remedies for PAH, in addition to new anti-proliferative therapies in energetic medical investigation, and what meaning for the way forward for remedy.
Topics Discussed:
• What is most new and thrilling within the remedy of pulmonary arterial hypertension?
• What monitoring is critical as a way to safely use sotatercept?
• What future developments do you envision for the sector of pulmonary hypertension?
From Mayo Clinic to your inbox, sign-up totally free: https://mayocl.in/3e71zfi
Visit Mayo Clinic: https://mayocl.in/2COVmlm
Like Mayo Clinic on Facebook: https://www.facebook.com/mayoclinic/
Follow Mayo Clinic on Instagram: https://www.instagram.com/mayoclinic/
Follow Mayo Clinic on X, previously Twitter: https://x.com/MayoClinic
Follow Mayo Clinic on Threads: https://www.threads.net/@mayoclinic
